Estrogen-Associated Headaches Can Be Treated by Surgery: A Multicenter Retrospective Cohort Study.
Journal
Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
pubmed:
9
8
2022
medline:
1
10
2022
entrez:
8
8
2022
Statut:
ppublish
Résumé
Nerve decompression surgery has been successful in treating headaches refractory to traditional medical therapies. Nevertheless, a subset of patients remains unresponsive to surgical treatment. The authors conducted a retrospective chart review of the two senior authors' (J.E.J. and W.G.A.) patient data from 2007 to 2020 to investigate differences in surgical outcomes in women reporting estrogen-associated headaches (headaches associated with menstrual period, oral contraceptives, pregnancy, or other hormonal drugs) compared with those who did not. For these two groups, the authors used the migraine headache index as the metric for headache severity and compared the mean percent change in migraine headache index score at 3 months and 1 year. Of the 99 female patients who underwent nerve decompression surgery and met inclusion criteria, 50 reported estrogen-associated headaches and were found to have significantly earlier age of onset ( p = 0.017) and initial presentation to clinic ( p = 0.046). At 1 year postoperatively, migraine headache index score had improved more than 80 percent in the majority of patients (67 percent), but there was a subset of patients whose score improved less than 5 percent (12.5 percent). The authors did not find a significant difference in percent change in postoperative migraine headache index score between women with estrogen-associated headaches and those without such headaches. Women with estrogen-associated headaches have surgical outcomes comparable to those of women without this association. Nerve decompression surgery should be offered to women experiencing estrogen-associated headaches as an option for treatment. Risk, II.
Sections du résumé
BACKGROUND
Nerve decompression surgery has been successful in treating headaches refractory to traditional medical therapies. Nevertheless, a subset of patients remains unresponsive to surgical treatment.
METHODS
The authors conducted a retrospective chart review of the two senior authors' (J.E.J. and W.G.A.) patient data from 2007 to 2020 to investigate differences in surgical outcomes in women reporting estrogen-associated headaches (headaches associated with menstrual period, oral contraceptives, pregnancy, or other hormonal drugs) compared with those who did not. For these two groups, the authors used the migraine headache index as the metric for headache severity and compared the mean percent change in migraine headache index score at 3 months and 1 year.
RESULTS
Of the 99 female patients who underwent nerve decompression surgery and met inclusion criteria, 50 reported estrogen-associated headaches and were found to have significantly earlier age of onset ( p = 0.017) and initial presentation to clinic ( p = 0.046). At 1 year postoperatively, migraine headache index score had improved more than 80 percent in the majority of patients (67 percent), but there was a subset of patients whose score improved less than 5 percent (12.5 percent). The authors did not find a significant difference in percent change in postoperative migraine headache index score between women with estrogen-associated headaches and those without such headaches.
CONCLUSIONS
Women with estrogen-associated headaches have surgical outcomes comparable to those of women without this association. Nerve decompression surgery should be offered to women experiencing estrogen-associated headaches as an option for treatment.
CLINICAL QUESTION/LEVEL OF EVIDENCE
Risk, II.
Identifiants
pubmed: 35939632
doi: 10.1097/PRS.0000000000009546
pii: 00006534-202210000-00031
doi:
Substances chimiques
Contraceptives, Oral
0
Estrogens
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
854e-862eInformations de copyright
Copyright © 2022 by the American Society of Plastic Surgeons.
Références
Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache 2018;58:700–714.
Hawkins K, Wang S, Rupnow MF. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49:368–374.
Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: Figures and trends from government health studies. Headache 2018;58:496–505.
Schulman E. Refractory migraine: A review. Headache 2013;53:599–613.
Irimia P, Palma JA, Fernandez-Torron R, Martinez-Vila E. Refractory migraine in a headache clinic population. BMC Neurol. 2011;11:94.
Goadsby PJ, Hargreaves R. Refractory migraine and chronic migraine: Pathophysiological mechanisms. Headache 2008;48:1399–1405.
Ong JJY, De Felice M. Migraine treatment: Current acute medications and their potential mechanisms of action. Neurotherapeutics 2018;15:274–290.
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev. 2017;97:553–622.
Tso AR, Goadsby PJ. Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention? Curr Treat Options Neurol. 2017;19:27.
Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000;106:429–434; discussion 435–437.
Gfrerer L, Guyuron B. Surgical treatment of migraine headaches. Acta Neurol Belg. 2017;117:27–32.
Blake P. Emerging evidence of occipital nerve compression in unremitting head and neck pain. J Headache Pain 2019;20:76.
Burstein R, Blake P, Schain A, Perry C. Extracranial origin of headache. Curr Opin Neurol. 2017;30:263–271.
de Ru JA, Filipovic B, Lans J, van der Veen EL, Lohuis PJ. Entrapment neuropathy: A concept for pathogenesis and treatment of headaches: A narrative review. Clin Med Insights Ear Nose Throat 2019;12:1179550619834949.
Omranifard M, Abdali H, Ardakani MR, Talebianfar M. A comparison of outcome of medical and surgical treatment of migraine headache: In 1 year follow-up. Adv Biomed Res. 2016;5:121.
Janis JE, Barker JC, Javadi C, Ducic I, Hagan R, Guyuron B. A review of current evidence in the surgical treatment of migraine headaches. Plast Reconstr Surg. 2014;134:131S–141S.
SpringerLink. Surgical treatment of chronic headaches and migraines. Published 2020. https://link.springer.com/book/10.1007/978-3-030-36794-7 . Accessed December 1, 2020.
Bink T, Duraku LS, Ter Louw RP, Zuidam JM, Mathijssen IMJ, Driessen C. The cutting edge of headache surgery: A systematic review on the value of extracranial surgery in the treatment of chronic headache. Plast Reconstr Surg. 2019;144:1431–1448.
Hatef DA, Gutowski KA, Culbertson GR, Zielinski M, Manahan MA. A comprehensive review of surgical treatment of migraine surgery safety and efficacy. Plast Reconstr Surg. 2020;146:187e–195e.
Guyuron B, Nahabet E, Khansa I, Reed D, Janis JE. The current means for detection of migraine headache trigger sites. Plast Reconstr Surg. 2015;136:860–867.
Rangwani SM, Hehr JD, Janis JE. Clinical effectiveness of peripheral nerve blocks for diagnosis of migraine trigger points. Plast Reconstr Surg Glob Open 2020;8(9 Suppl).
Gfrerer L, Hulsen JH, McLeod MD, Wright EJ, Austen WG Jr. Migraine surgery: An all or nothing phenomenon? Prospective evaluation of surgical outcomes. Ann Surg. 2019;269:994–999.
Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis: Part 2. Headache 2006;46:365–386.
Lipton RB, Bigal ME. Migraine: Epidemiology, impact, and risk factors for progression. Headache 2005;45(Suppl 1):S3–S13.
MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006;67:2154–2158.
Pavlović JM, Allshouse AA, Santoro NF, et al. Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles. Neurology 2016;87:49–56.
Silberstein SD. The role of sex hormones in headache. Neurology 1992;42(3 Suppl 2):37–42.
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: The role of hormones and their impact on vascular diseases. J Headache Pain 2012;13:177–189.
Welch KM, Brandes JL, Berman NE. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci. 2006;27(Suppl 2):S190–S192.
Brandes JL. The influence of estrogen on migraine: A systematic review. JAMA. 2006;295:1824–1830.
Tietjen GE, Herial NA, White L, Utley C, Kosmyna JM, Khuder SA. Migraine and biomarkers of endothelial activation in young women. Stroke 2009;40:2977–2982.
Willis C, Morris JM, Danis V, Gallery ED. Cytokine production by peripheral blood monocytes during the normal human ovulatory menstrual cycle. Hum Reprod. 2003;18:1173–1178.
Puri V, Cui L, Liverman CS, et al. Ovarian steroids regulate neuropeptides in the trigeminal ganglion. Neuropeptides 2005;39:409–417.
Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: Prevalence, disability and treatment. Cephalalgia 2003;23:302–308.
Gfrerer L, Austen WG Jr, Janis JE. Migraine surgery. Plast Reconstr Surg Glob Open 2019;7:e2291.
Chai NC, Peterlin BL, Calhoun AH. Migraine and estrogen. Curr Opin Neurol. 2014;27:315–324.
Borsook D, Erpelding N, Lebel A, et al. Sex and the migraine brain. Neurobiol Dis. 2014;68:200–214.
Maleki N, Linnman C, Brawn J, Burstein R, Becerra L, Borsook D. Her versus his migraine: Multiple sex differences in brain function and structure. Brain 2012;135(Pt 8):2546–2559.
Puri J, Bellinger LL, Kramer PR. Estrogen in cycling rats alters gene expression in the temporomandibular joint, trigeminal ganglia and trigeminal subnucleus caudalis/upper cervical cord junction. J Cell Physiol. 2011;226:3169–3180.
Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355–365.
Pereira V, Goudet C. Emerging trends in pain modulation by metabotropic glutamate receptors. Front Mol Neurosci. 2018;11:464.
Schmid AB, Fundaun J, Tampin B. Entrapment neuropathies: A contemporary approach to pathophysiology, clinical assessment, and management. Pain Rep. 2020;5:e829.
Donegan M, Kernisant M, Cua C, Jasmin L, Ohara PT. Satellite glial cell proliferation in the trigeminal ganglia after chronic constriction injury of the infraorbital nerve: SGC proliferation after nerve injury. Glia 2013;61:2000–2008.
Ohara PT, Vit JP, Bhargava A, et al. Gliopathic pain: When satellite glial cells go bad. Neuroscientist 2009;15:450–463.
Upton AR, McComas AJ. The double crush in nerve entrapment syndromes. Lancet 1973;2:359–362.
Dellon AL, Mackinnon SE. Chronic nerve compression model for the double crush hypothesis. Ann Plast Surg. 1991;26:259–264.
Dellon AL. Susceptibility of nerve in diabetes to compression: Implications for pain treatment. Plast Reconstr Surg. 2014;134:142S–150S.
Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women’s hormonal migraine: The depo-estradiol challenge test. Headache 1996;36:367–371.
Ryan RE. A controlled study of the effect of oral contraceptives on migraine. Headache 1978;17:250–252.
Mueller L. Predictability of exogenous hormone effect on subgroups of migraineurs. Headache 2000;40:189–193.
Hodson J, Thompson J, al-Azzawi F. Headache at menopause and in hormone replacement therapy users. Climacteric 2000;3:119–124.
Misakian AL, Langer RD, Bensenor IM, et al. Postmenopausal hormone therapy and migraine headache. J Womens Health 2003;12:1027–1036.
Guyuron B, Kriegler JS, Davis J, Amini SB. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg. 2011;127:603–608.